Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 6Anemia 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 4Therapeutics 2Filgrastim 2Ferric Oxide, Saccharated 2Cyclophosphamide 2Busulfan 2venetoclax 1trametinib 1ruxolitinib 1reolysin 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1fludarabine phosphate 1fludarabine 1ferrous sulfate 1ferric gluconate 1epoetin beta 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × reolysin × Plasma cell × Clear all
NCT02101944 2024-05-17

Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Classical hematologyPlasma cell

Anemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡